Top

The journal of nutrition, health & aging

Published in:

01-01-2018

Dynapenic Abdominal Obesity Increases Mortality Risk Among English and Brazilian Older Adults: A 10-Year Follow-Up of the ELSA and SABE Studies

Authors: Tiago da Silva Alexandre, S. Scholes, J. L. Ferreira Santos, Y. A. de Oliveira Duarte, C. de Oliveira

Published in: The journal of nutrition, health & aging | Issue 1/2018

Abstract

Background/Objective

There is little epidemiological evidence demonstrating that dynapenic abdominal obesity has higher mortality risk than dynapenia and abdominal obesity alone. Our main aim was to investigate whether dynapenia combined with abdominal obesity increases mortality risk among English and Brazilian older adults over ten-year follow-up.

Design

Cohort study.

Setting

United Kingdom and Brazil.

Participants

Data came from 4,683 individuals from the English Longitudinal Study of Ageing (ELSA) and 1,490 from the Brazilian Health, Well-being and Aging study (SABE), hence the final sample of this study was 6,173 older adults.

Measurements

The study population was categorized into the following groups: nondynapenic/ non-abdominal obese, abdominal obese, dynapenic, and dynapenic abdominal obese according to their handgrip strength (< 26 kg for men and < 16 kg for women) and waist circumference (> 102 cm for men and > 88 cm for women). The outcome was all-cause mortality over a ten-year follow-up. Adjusted hazard ratios by sociodemographic, behavioural and clinical characteristics were estimated using Cox proportional hazards models. Results: The fully adjusted model showed that dynapenic abdominal obesity has a higher mortality risk among the groups. The hazard ratios (HR) were 1.37 for dynapenic abdominal obesity (95% CI = 1.12–1.68), 1.15 for abdominal obesity (95% CI = 0.98–1.35), and 1.23 for dynapenia (95% CI = 1.04–1.45).

Conclusions

Dynapenia is an important risk factor for mortality but dynapenic abdominal obesity has the highest mortality risk among English and Brazilian older adults.

Available only for authorised users

He W, Goodkind D, Kowal P. An Aging World: 2015 International Population Reports. United States Census Bureau. US Department of Commerce Economics and Statistics Administration, US Department of Health and Human Services National Institutes of Health, National Institute of Aging, 2016.

Hamer M, Batty D, Kivimaki M. Risk of future depression in people who are obese but metabolically healthy: The English Longitudinal Study of Ageing. Mol Psychiatry 2012;17(9):940–945.CrossRefPubMedPubMedCentral

Al Snih S, Graham JEG, Kuo YF, et al. Obesity and disability: Relation among older adults living in Latin America and the Caribbean. American Journal of Epidemiology 2010;171(12):1282–1288.CrossRefPubMedPubMedCentral

Samper-Ternent R, Al Snih S. Obesity in older adults: Epidemiology and implications for disability and disease. Reviews in Clinical Gerontology 2012;22:10–34.CrossRefPubMedPubMedCentral

Clark BC, Manini TM. Sarcopenia # Dynapenia. Journal of Gerontology A: Biological Sciences Medical Sciences 2008;63A(8):829–34.

Clark BC, Manini TM. What is dynapenia? Nutrition 28(5):495-503.

Delmonico MJ, Harris TB, Visser M, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. The American Journal of Clinical Nutrition 2009;90(6):1579–85.CrossRefPubMedPubMedCentral

Schaap LA, Koster A, Visser M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons. Epidemiologic Reviews 2013;35(1):51–65.CrossRefPubMed

Schaap LA, Pluijm SM, Deeg DJ, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2009;64(11):1183–1189.CrossRef

10.

Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women The Health ABC Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002;57(5):M326–M332.CrossRef

11.

Volaklis KA, Halle M, Meisinger C. Muscular strength as a strong predictor of mortality: A narrative review. European Journal of Internal Medicine 2015;26:303–310.CrossRefPubMed

12.

Alexandre TS, Duarte YAO, Santos JLF, et al. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. The Journal of Nutrition, Health & Aging 2014;18:751–756.CrossRef

13.

Stenholm S, Mehta NK, Elo IT, et al. Obesity and muscle strength as long-term determinants of all-cause mortality–a 33 year of follow-up of the Mini-Finland Health Examination Survey. Int J Obes 2014;38(8):1126–1132.CrossRef

14.

Rossi AP, Fantin F, Caliani C, et al. Dynapenic abdominal obesity as predictor of mortality and disability worsening in older adults: A 10-year prospective study. Clinical Nutrition 2016;35:199–204.CrossRefPubMed

15.

Mindell J, Biddulph JP, Hirani V, et al. Cohort profile: the health survey for England. Int J Epidemiol 2012;41(6):1585–93.CrossRefPubMed

16.

Steptoe A, Breeze E, Banks J, et al. Cohort Profile: The English Longitudinal Study of Ageing. Int J Epidemiol 2013;42:1640–1648.CrossRefPubMed

17.

Alexandre TS, Corona LP, Nunes DP, et al. Disability in instrumental activities of daily living among older adults: gender differences. Rev Saúde Publ 2014;48(3):378–389.CrossRef

18.

Lebrão ML, Laurenti, R. Health, Well-being and Aging: The SABE study in São Paulo, Brazil. Rev Bras Epidemiol 2005;8:127–41.CrossRef

19.

NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda (MD): National Heart, Lung, and Blood Institute; 1998 Sep.

20.

Alexandre TS, Duarte YAO, Santos JLF, et al. Prevalence and associated factors of sarcopenia among elderly in Brazil: findings from the SABE Study. J Nutr Health Aging 2014;18(3):285–290.

21.

McLean RR, Shardell MD, Alley DE, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2014;69(5):576–583.CrossRefPubMedCentral

22.

World Health Organization. Consultation on obesity. Obesity: preventing and managing the global epidemic. Geneva, Switzerland: WHO; 2000. WHO Technical Report Series894.

23.

Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. Journal of the American Medical Association 1963;185:914–19.PubMed

24.

Lawton MP. The functional assessment of elderly people. Journal of the American Geriatrics Society 1971;19(6):465–481.CrossRefPubMed

25.

Carmienke S, Freitag MH, Pischon T et al. General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and metaregression analysis. Eur J Clin Nutr 2013;67:573–585.CrossRefPubMed

26.

Zamboni M, Mazzalli G, Zoico E, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes 2005;29:1011–1029.CrossRef

27.

Rossner S. Obesity in the elderly–a future matter of concern? Obes Rev. 2001;2:183–188.CrossRefPubMed

28.

Inelmen EM, Sergi G, Coin A, et al. Can obesity be a risk factor for elderly people? Obes Rev 2003;4:147–155.CrossRefPubMed

29.

Elia M. Obesity in the elderly. Obes Res 2001;9:244S–248S.CrossRefPubMed

30.

Folsom AR, Kushi LH, Anderson KE, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Womens Health Study. Arch Intern Med 2000;160:2117–2128.CrossRefPubMed

31.

Garrison RJ, Feinleib M, Catelli WP, et al. Cigarette smoking as a confounder of the relationship between relative weight and long-term mortality. The Framingham Heart Study. JAMA 1983;249:2199–2203.PubMed

32.

Sempos CT, Durazo-Arvizu R, McGee DL, et al. The influence of cigarette smoking on the association between body weight and mortality. The Framingham Heart Study revisited. Ann Epidemiol 1998;8:289–300.PubMed

33.

Hair JF, Anderson RE, Tatham RL et al. Multivariate data analysis with readings. Upper Saddle River, NJ: Prentice Hall 1995.

34.

Zamboni M, Armellini F, Harris T, et al. Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr 1997;66:111–115.CrossRefPubMed

35.

Sahakyan KR, Somers VK, Rodriguex-Escudero JP, et al. Normal-weight central obesity: Implications for total and cardiovascular mortality. Annals of Internal Medicine 2015;163:827–835.CrossRefPubMedPubMedCentral

36.

Harris TB, Visser M, Everhart J, et al. Waist circumference and sagittal diameter reflect total body fat better than visceral fat in older men and women. The health, aging and body composition study. Ann NY Acad Sci 2000;904:462–473.CrossRefPubMed

37.

Ho SC, Chen YM, Woo JLF, et al. Association between simple anthropometric indices and cardiovascular risk factors. Int J Obes Relat Metab Disord 2001;25:1689–1697.CrossRefPubMed

38.

Van Gall LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006;44:878–80.

39.

Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89;2595–600.CrossRefPubMed

40.

Navab M, Anantharamaiah GM, Fogelman AM. The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med 2005;15:158–161.CrossRefPubMed

41.

Després JP. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. J Endocrinol Invest 2006;29:77–82.PubMed

42.

Atlantis E, Martin SA, Haren MT, et al. Inverse association between muscle mass, strength and the metabolic syndrome. Metabolism 2009;58(7):1013–1022.CrossRefPubMed

43.

Srikanthan P, Karlamanglia AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third NHNES. J Clin Endocrionol Metabol 2001;96(9):2898–2903.CrossRef

44.

Sénéchal M, Dionne IJ, Brochu M. Dynapenic abdominal obesity and metabolic risk factors in adults 50 years of age and older. Journal of Aging and Health 2012;24:812–826.CrossRefPubMed

45.

Zunzunegui MV, Alvarado B, Béland F, et al. Explaining health differences between men and women in later life: A cross-city comparison in Latin America and the Caribbean. Social Science and Medicine 2009;68:235–242.CrossRefPubMed

Title: Dynapenic Abdominal Obesity Increases Mortality Risk Among English and Brazilian Older Adults: A 10-Year Follow-Up of the ELSA and SABE Studies
Authors: Tiago da Silva Alexandre
S. Scholes
J. L. Ferreira Santos
Y. A. de Oliveira Duarte
C. de Oliveira
Publication date: 01-01-2018
Publisher: Springer Paris
Published in: The journal of nutrition, health & aging / Issue 1/2018
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI: https://doi.org/10.1007/s12603-017-0966-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Dynapenic Abdominal Obesity Increases Mortality Risk Among English and Brazilian Older Adults: A 10-Year Follow-Up of the ELSA and SABE Studies

Abstract

Background/Objective

Design

Setting

Participants

Measurements

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background/Objective

Design

Setting

Participants

Measurements

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Lower 25-Hydroxyvitamin D is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis

Orthostatic Hypotension and Associated Factors Among Home Care Clients Aged 75 Years or Older - A Population-Based Study

Real-Life Peak and Trough Dabigatran Plasma Measurements Over Time in Hospitalized Geriatric Patients with Atrial Fibrillation

The My Meal Intake Tool (M-MIT): Validity of a Patient Self-Assessment for Food and Fluid Intake at a Single Meal

Association of Serum 25(OH) D Levels with Infarct Volumes and Stroke Severity in Acute Ischemic Stroke

Feasibility, Acceptability and Effects of a Home-Based Exercise Program Using a Gerontechnology on Physical Capacities After a Minor Injury in Community-Living Older Adults: A Pilot Study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page